Abstract
Author response for "Extracellular <scp>LGALS3BP</scp> : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma"
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have